Docetaxel and Irinotecan in Gastric Cancer

NCT04770623 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Stomach Cancer
Gastric Cancer
Chemotherapy Effect

Interventions

DRUG: Docetaxel
DRUG: Irinotecan

Sponsor

Menoufia University